Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesFelix Bayerl, Jan P. Böttcher, Sainitin Donakonda et al.|Immunity|2023Cited by 176
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic LesionsAnne Zaremba, Klaus Griewank|Cancers|2022Cited by 1